Do I have a defective drug case?
Free Case Evaluation - Our full time staff is ready to evaluate your case submission and will respond in a timely manner.
Zofran is an anti-nausea drug intended to help cancer patients undergoing treatment. However, it is a drug that is often used "off-label" to treat pregnant women experiencing morning sickness. This drug has been linked to numerous reports of birth defects. In fact, studies have shown a 30 percent increased risk of birth defects, particularly heart defects and cleft palates, among children of women who took Zofran during pregnancy.
The pharmaceutical litigation lawyers of Bisnar Chase is currently helping those who have suffered side effects and life-changing consequences as a result of taking the drug Zofran during pregnancy. If your child suffered birth defects because you took Zofran while pregnant to treat your morning sickness, call us at (800) 561-4887 to find out how we can help you. You are entitled to a free consultation.
The value of your case will depend on factors such as the seriousness of your child's condition and the effect it has on your child and the family. Victims of Zofran birth defects can seek compensation for damages including medical expenses, cost of surgeries, hospitalization, future medical expenses, pain and suffering and mental anguish. An experienced Zofran lawyer can help evaluate your case and help you receive maximum compensation for your significant losses.
Zofran (generic name: ondansetron) is an anti-nausea drug, which was approved by the U.S. Food and Drug Administration (FDA) for cancer patients undergoing chemotherapy and surgery. The drug is manufactured by GlaxoSmithKline and has been in the market since 1991. It is important to note that the FDA did not approve the use of Zofran to treat symptoms of morning sickness in pregnant women.
This is known as an "off-label" use for the drug. The FDA categorizes Zofran as a "Category B" drug during pregnancy. This means that there are no test data to prove that this drug is safe for pregnant women to use. Zofran has also been linked to deadly or devastating side effects for the children of pregnant women to took them to treat nausea.
According to several recent research studies, it has been proven that Zofran is passed from the mother to the fetus through the placenta. Also, studies show that the effects of the drug remain active in the baby much longer than they are in the mother. Studies conducted over the last five years by researchers in Denmark and Australia have found that women who take Zofran during pregnancy or two or three times more likely to give birth to children with birth defects.
Here are some of the most common birth defects reported in children whose mothers took Zofran during pregnancy:
The Department of Justice sued GlaxoSmithKline, the manufacturer of Zofran, for illegal promotion and failure to report safety data for many of its drugs including Zofran. The pharmaceutical giant not only pleaded guilty to illegally promoting Zofran to treat morning sickness in pregnant women, but also agreed to pay $3 billion in 2012 to resolve those charges. The company is also facing civil lawsuits from families of children who have suffered birth defects as a result of the drug.
The California pharmaceutical attorneys at Bisnar Chase are passionate in the pursuit of justice for individuals and families that have been devastated by the negligence of corporations that manufacture dangerous and defective products. We are committed to holding these companies accountable for the injuries and long-term damages they cause. Our unique no-fee guarantee helps ensure that you don't pay anything until we secure compensation for you. For a free consultation and comprehensive case evaluation, call us at (800) 561-4887.